Loading...
Plasma pharmacokinetics of high-affinity transferrin receptor antibody-erythropoietin fusion protein is a function of effector attenuation in mice
Erythropoietin (EPO) is a potential therapeutic for Alzheimer’s disease (AD), however limited blood-brain barrier (BBB) penetration reduces its applicability as a CNS therapeutic. Antibodies against the BBB transferrin receptor (TfRMAbs) act as molecular Trojan horses for brain drug delivery, and a...
Na minha lista:
| Udgivet i: | Mol Pharm |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6684820/ https://ncbi.nlm.nih.gov/pubmed/31199881 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acs.molpharmaceut.9b00369 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|